By Angela Yeager – Oregon Health & Science University –
The NIH award supports development of stem cells designed to avoid immune rejection, preserve vision.
Millions of older adults face vision loss from age-related macular degeneration, or AMD, a leading cause of irreversible blindness. A researcher at Oregon Health & Science University has received a major federal grant to develop a new generation of stem cell therapies that could one day help preserve sight for those with the disease without requiring long-term immune-suppressing drugs.
